Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer
Authors
Keywords
Pancreatic cancer, Chemoresistance, ceRNA, lncRNA, GSTM3TV2, Prognosis
Journal
Journal of Hematology & Oncology
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-12
DOI
10.1186/s13045-019-0777-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Noncoding RNAs in cancer therapy resistance and targeted drug development
- (2019) Wen-Tao Wang et al. Journal of Hematology & Oncology
- Long non-coding RNA GAS5 antagonizes the chemoresistance of pancreatic cancer cells through down-regulation of miR-181c-5p
- (2018) Zhi-Qiang Gao et al. BIOMEDICINE & PHARMACOTHERAPY
- LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein
- (2018) Yan Liang et al. CELL DEATH AND DIFFERENTIATION
- MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma
- (2018) Guangbing Xiong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- LncRNA TUG1 promoted viability and associated with gemcitabine resistant in pancreatic ductal adenocarcinoma
- (2018) Fan Yang et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Emerging roles of long non-coding RNAs in tumor metabolism
- (2018) Hui Sun et al. Journal of Hematology & Oncology
- The Network of Non-coding RNAs in Cancer Drug Resistance
- (2018) Fabio Corrà et al. Frontiers in Oncology
- LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
- (2018) Mengyu Feng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207
- (2018) Lei You et al. Molecular Oncology
- lncRNA GAS5 Reverses EMT and Tumor Stem Cell-Mediated Gemcitabine Resistance and Metastasis by Targeting miR-221/SOCS3 in Pancreatic Cancer
- (2018) Bingyan Liu et al. Molecular Therapy-Nucleic Acids
- A competing endogenous RNA network identifies novel mRNA, miRNA and lncRNA markers for the prognosis of diabetic pancreatic cancer
- (2017) Kanyu Yao et al. TUMOR BIOLOGY
- H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance
- (2017) Fei Peng et al. Cell Death & Disease
- Linc-DYNC2H1-4 promotes EMT and CSC phenotypes by acting as a sponge of miR-145 in pancreatic cancer cells
- (2017) Yuran Gao et al. Cell Death & Disease
- The long intergenic non-coding RNA CCR492 functions as a let-7 competitive endogenous RNA to regulate c-Myc expression
- (2016) Mara Maldotti et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA
- (2016) Le Qu et al. CANCER CELL
- Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis
- (2016) Chenggang Li et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer
- (2016) Beatrice Bissig-Choisat et al. JOURNAL OF HEPATOLOGY
- Pancreatic cancer
- (2016) Terumi Kamisawa et al. LANCET
- Unique features of long non-coding RNA biogenesis and function
- (2016) Jeffrey J. Quinn et al. NATURE REVIEWS GENETICS
- Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer
- (2016) Meng Zhou et al. Oncotarget
- Gemcitabine resistance in pancreatic ductal adenocarcinoma
- (2015) Yoav Binenbaum et al. DRUG RESISTANCE UPDATES
- Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge
- (2015) Liang Deng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma
- (2015) Yibiao Ye et al. Journal of Translational Medicine
- The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer
- (2015) Zhihua Li et al. Journal of Translational Medicine
- The emerging role of lncRNAs in cancer
- (2015) Maite Huarte NATURE MEDICINE
- Pancreatic Adenocarcinoma
- (2015) David P. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis
- (2015) Jianwei Xu et al. Oncotarget
- The multilayered complexity of ceRNA crosstalk and competition
- (2014) Yvonne Tay et al. NATURE
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environments
- (2013) U. Ala et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: A meta-analysis of randomised trials
- (2012) Domenico Ciliberto et al. EUROPEAN JOURNAL OF CANCER
- Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells
- (2011) Lei You et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oxidized LDL Receptor 1 (OLR1) as a Possible Link between Obesity, Dyslipidemia and Cancer
- (2011) Magomed Khaidakov et al. PLoS One
- A Transcriptional Signature and Common Gene Networks Link Cancer with Lipid Metabolism and Diverse Human Diseases
- (2010) Heather A. Hirsch et al. CANCER CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started